Blockade of neutrophil recruitment to tumor sites based on sialic acid-modified nanoplatforms enhances the efficacy of checkpoint blockade immunotherapy
Checkpoint inhibitors are designed to rejuvenate depleted or suppressed T cells in the tumor microenvironment, relying on the immune system to control and kill tumors. However, accumulating evidence indicates that tumor-infiltrating neutrophils impede the proliferation and activation of T cells and...
Saved in:
Main Authors: | Meng Chen (Author), Zhaowei Qi (Author), Xianmin Meng (Author), Shuo Wang (Author), Xueying Zheng (Author), Miao Hu (Author), Xinrong Liu (Author), Yanzhi Song (Author), Yihui Deng (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sialic acid-mediated photochemotherapy enhances infiltration of CD8+ T cells from tumor-draining lymph nodes into tumors of immunosenescent mice
by: Dezhi Sui, et al.
Published: (2023) -
The Fate of Sialic Acid and PEG Modified Epirubicin Liposomes in Aged versus Young Cells and Tumor Mice Models
by: Dezhi Sui, et al.
Published: (2022) -
Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator
by: Qingqing Xiao, et al.
Published: (2023) -
Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
by: Yuxuan Liu, et al.
Published: (2024) -
Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy
by: Yongrong Yao, et al.
Published: (2022)